132 related articles for article (PubMed ID: 37014329)
1. FKBP11 improves the malignant property of osteosarcoma cells and acts as a prognostic factor of osteosarcoma.
Zeng D; Li J; Yuan X; Cai F; Yu B; Liu L; Chen Q; Zhang F; Liang Y; Tang X; Peng Y; Qu G; Wu P; Jiao Q; Sun L; Lv XB; Liao Q
Aging (Albany NY); 2023 Apr; 15(7):2450-2459. PubMed ID: 37014329
[TBL] [Abstract][Full Text] [Related]
2. FKBP11 promotes cell proliferation and tumorigenesis via p53-related pathways in oral squamous cell carcinoma.
Qiu L; Liu H; Wang S; Dai XH; Shang JW; Lian XL; Wang GH; Zhang J
Biochem Biophys Res Commun; 2021 Jun; 559():183-190. PubMed ID: 33945996
[TBL] [Abstract][Full Text] [Related]
3. FKBP11 upregulation promotes proliferation and migration in hepatocellular carcinoma.
Thokerunga E; Huang F; Bongolo CC; Rugera SP; Akankwatsa G; Tu JC
Cancer Biomark; 2023; 37(2):109-120. PubMed ID: 37248890
[TBL] [Abstract][Full Text] [Related]
4. GREM1 overexpression inhibits proliferation, migration and angiogenesis of osteosarcoma.
Gu Q; Luo Y; Chen C; Jiang D; Huang Q; Wang X
Exp Cell Res; 2019 Nov; 384(1):111619. PubMed ID: 31525341
[TBL] [Abstract][Full Text] [Related]
5. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
Zhang Y; Wang F; Wang L; Zhang Q
World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945
[TBL] [Abstract][Full Text] [Related]
6. ARHGAP44-mediated regulation of the p53/C-myc/Cyclin D1 pathway in modulating the malignant biological behavior of osteosarcoma cells.
Li S; Xue J; Zhang H; Shang G
J Orthop Surg Res; 2023 Nov; 18(1):910. PubMed ID: 38031136
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
8. Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK/AP-1 signaling pathway.
Han Y; Zhao X; Sun Y; Sui Y; Liu J
J Cell Physiol; 2019 Apr; 234(4):3598-3612. PubMed ID: 30471098
[TBL] [Abstract][Full Text] [Related]
9. PDCD10 promotes proliferation, migration, and invasion of osteosarcoma by inhibiting apoptosis and activating EMT pathway.
Xu K; Fei W; Huo Z; Wang S; Li Y; Yang G; Hong Y
Cancer Med; 2023 Jan; 12(2):1673-1684. PubMed ID: 35848121
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
Liu ZB; Wang JA; Lv RQ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
[TBL] [Abstract][Full Text] [Related]
11. Long Noncoding RNA HCG9 Promotes Osteosarcoma Progression through RAD51 by Acting as a ceRNA of miR-34b-3p.
Wang L; Li S; Qi L; Ling L
Mediators Inflamm; 2021; 2021():9978882. PubMed ID: 34456631
[TBL] [Abstract][Full Text] [Related]
12. PLOD1 Is a Prognostic Biomarker and Mediator of Proliferation and Invasion in Osteosarcoma.
Jiang H; Guo W; Yuan S; Song L
Biomed Res Int; 2020; 2020():3418398. PubMed ID: 33134376
[TBL] [Abstract][Full Text] [Related]
13. Knocking down miR-384 promotes growth and metastasis of osteosarcoma MG63 cells by targeting SLBP.
Wang Y; Huang H; Li Y
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1458-1465. PubMed ID: 31007083
[TBL] [Abstract][Full Text] [Related]
14. AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway.
Zheng J; Liu C; Shi J; Wen K; Wang X
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913077
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of RBM10 induces osteosarcoma cell apoptosis and inhibits cell proliferation and migration.
Han LP; Wang CP; Han SL
Med Sci (Paris); 2018 Oct; 34 Focus issue F1():81-86. PubMed ID: 30403180
[TBL] [Abstract][Full Text] [Related]
16. miR-541 serves as a prognostic biomarker of osteosarcoma and its regulatory effect on tumor cell proliferation, migration and invasion by targeting TGIF2.
Liu C; Yi X
Diagn Pathol; 2020 Jul; 15(1):96. PubMed ID: 32709240
[TBL] [Abstract][Full Text] [Related]
17. PSMC2 is up-regulated in osteosarcoma and regulates osteosarcoma cell proliferation, apoptosis and migration.
Song M; Wang Y; Zhang Z; Wang S
Oncotarget; 2017 Jan; 8(1):933-953. PubMed ID: 27888613
[TBL] [Abstract][Full Text] [Related]
18. Effects of PAK4/LIMK1/Cofilin-1 signaling pathway on proliferation, invasion, and migration of human osteosarcoma cells.
Li ZF; Yao YD; Zhao YY; Liu Y; Liu ZH; Hu P; Zhu ZR
J Clin Lab Anal; 2020 Sep; 34(9):e23362. PubMed ID: 32463132
[TBL] [Abstract][Full Text] [Related]
19. MiR-451 suppresses proliferation, migration and promotes apoptosis of the human osteosarcoma by targeting macrophage migration inhibitory factor.
Liu W; Liu SY; He YB; Huang RL; Deng SY; Ni GX; Yu B
Biomed Pharmacother; 2017 Mar; 87():621-627. PubMed ID: 28086136
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance and effect of PRR 11 up-regulation on the malignancy of osteosarcoma.
Tan R; Zhao C; Lu Y; Chen L
Pol J Pathol; 2022; 73(3):264-276. PubMed ID: 36734441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
